Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS INDUSTRY
2.1 Summary about Active Pharmaceutical Ingredients Industry
2.2 Active Pharmaceutical Ingredients Market Trends
2.2.1 Active Pharmaceutical Ingredients Production & Consumption Trends
2.2.2 Active Pharmaceutical Ingredients Demand Structure Trends
2.3 Active Pharmaceutical Ingredients Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Synthetic APIs
4.2.2 Biotech APIs
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 CNS
4.3.2 Cardiovascular
4.3.3 Genitourinary/Hormonal Drugs
4.3.4 Respiratory
4.3.5 Rheumatology
4.3.6 Diabetes
4.3.7 Oncology
4.3.8 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Synthetic APIs
5.2.2 Biotech APIs
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 CNS
5.3.2 Cardiovascular
5.3.3 Genitourinary/Hormonal Drugs
5.3.4 Respiratory
5.3.5 Rheumatology
5.3.6 Diabetes
5.3.7 Oncology
5.3.8 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Synthetic APIs
6.2.2 Biotech APIs
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 CNS
6.3.2 Cardiovascular
6.3.3 Genitourinary/Hormonal Drugs
6.3.4 Respiratory
6.3.5 Rheumatology
6.3.6 Diabetes
6.3.7 Oncology
6.3.8 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Synthetic APIs
7.2.2 Biotech APIs
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 CNS
7.3.2 Cardiovascular
7.3.3 Genitourinary/Hormonal Drugs
7.3.4 Respiratory
7.3.5 Rheumatology
7.3.6 Diabetes
7.3.7 Oncology
7.3.8 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Synthetic APIs
8.2.2 Biotech APIs
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 CNS
8.3.2 Cardiovascular
8.3.3 Genitourinary/Hormonal Drugs
8.3.4 Respiratory
8.3.5 Rheumatology
8.3.6 Diabetes
8.3.7 Oncology
8.3.8 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Synthetic APIs
9.2.2 Biotech APIs
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 CNS
9.3.2 Cardiovascular
9.3.3 Genitourinary/Hormonal Drugs
9.3.4 Respiratory
9.3.5 Rheumatology
9.3.6 Diabetes
9.3.7 Oncology
9.3.8 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Teva
10.1.2 Mylan
10.1.3 DSM
10.1.4 Aurobindo Pharma
10.1.5 Aspen
10.1.6 Novartis
10.1.7 BASF
10.1.8 Pfizer
10.1.9 Huahai Pharmaceutical
10.1.10 Hisun Pharmaceutical
10.1.11 Sun Pharmaceutical Industries
10.1.12 Zhejiang Medicine
10.1.13 Dr. Reddy’s Laboratories
10.1.14 Zhejiang NHU
10.1.15 Bayer
10.1.16 NCPC
10.1.17 AbbVie
10.1.18 Shandong Xinhua Pharmaceutical
10.1.19 Northeast Pharm
10.1.20 Harbin Pharmaceutical
10.1.21 LKPC
10.2 Active Pharmaceutical Ingredients Sales Date of Major Players (2017-2020e)
10.2.1 Teva
10.2.2 Mylan
10.2.3 DSM
10.2.4 Aurobindo Pharma
10.2.5 Aspen
10.2.6 Novartis
10.2.7 BASF
10.2.8 Pfizer
10.2.9 Huahai Pharmaceutical
10.2.10 Hisun Pharmaceutical
10.2.11 Sun Pharmaceutical Industries
10.2.12 Zhejiang Medicine
10.2.13 Dr. Reddy’s Laboratories
10.2.14 Zhejiang NHU
10.2.15 Bayer
10.2.16 NCPC
10.2.17 AbbVie
10.2.18 Shandong Xinhua Pharmaceutical
10.2.19 Northeast Pharm
10.2.20 Harbin Pharmaceutical
10.2.21 LKPC
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
1.Table Active Pharmaceutical Ingredients Product Type Overview
2.Table Active Pharmaceutical Ingredients Product Type Market Share List
3.Table Active Pharmaceutical Ingredients Product Type of Major Players
4.Table Brief Introduction of Teva
5.Table Brief Introduction of Mylan
6.Table Brief Introduction of DSM
7.Table Brief Introduction of Aurobindo Pharma
8.Table Brief Introduction of Aspen
9.Table Brief Introduction of Novartis
10.Table Brief Introduction of BASF
11.Table Brief Introduction of Pfizer
12.Table Brief Introduction of Huahai Pharmaceutical
13.Table Brief Introduction of Hisun Pharmaceutical
14.Table Brief Introduction of Sun Pharmaceutical Industries
15.Table Brief Introduction of Zhejiang Medicine
16.Table Brief Introduction of Dr. Reddy’s Laboratories
17.Table Brief Introduction of Zhejiang NHU
18.Table Brief Introduction of Bayer
19.Table Brief Introduction of NCPC
20.Table Brief Introduction of AbbVie
21.Table Brief Introduction of Shandong Xinhua Pharmaceutical
22.Table Brief Introduction of Northeast Pharm
23.Table Brief Introduction of Harbin Pharmaceutical
24.Table Brief Introduction of LKPC
25.Table Products & Services of Teva
26.Table Products & Services of Mylan
27.Table Products & Services of DSM
28.Table Products & Services of Aurobindo Pharma
29.Table Products & Services of Aspen
30.Table Products & Services of Novartis
31.Table Products & Services of BASF
32.Table Products & Services of Pfizer
33.Table Products & Services of Huahai Pharmaceutical
34.Table Products & Services of Hisun Pharmaceutical
35.Table Products & Services of Sun Pharmaceutical Industries
36.Table Products & Services of Zhejiang Medicine
37.Table Products & Services of Dr. Reddy’s Laboratories
38.Table Products & Services of Zhejiang NHU
39.Table Products & Services of Bayer
40.Table Products & Services of NCPC
41.Table Products & Services of AbbVie
42.Table Products & Services of Shandong Xinhua Pharmaceutical
43.Table Products & Services of Northeast Pharm
44.Table Products & Services of Harbin Pharmaceutical
45.Table Products & Services of LKPC
46.Table Market Distribution of Major Players
47.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
48.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
49.Table Global Active Pharmaceutical Ingredients Market Forecast (Million USD) by Region 2021f-2026f
50.Table Global Active Pharmaceutical Ingredients Market Forecast (Million USD) Share by Region 2021f-2026f
51.Table Global Active Pharmaceutical Ingredients Market Forecast (Million USD) by Demand 2021f-2026f
52.Table Global Active Pharmaceutical Ingredients Market Forecast (Million USD) Share by Demand 2021f-2026f